A Novel Treatment Strategy Targeting Aurora Kinases in Acute Myelogenous Leukemia

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-07-0067
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Molecular Pathways: Targeting NRAS in Melanoma and Acute Myelogenous Leukemia

Clinical Cancer Research
Cancer ResearchOncology
2014English

Treatment of Acute Myelogenous Leukemia in Older Adults

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2000English

Targeting the Thioredoxin System as a Novel Strategy Against B Cell Acute Lymphoblastic Leukemia

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2019English

Targeting the PIM Protein Kinases for the Treatment of a T-Cell Acute Lymphoblastic Leukemia Subset

Oncotarget
Oncology
2017English

Dual Targeting of Aurora Kinases With AMG 900 Exhibits Potent Preclinical Activity Against Acute Myeloid Leukemia With Distinct Post-Mitotic Outcomes

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

New Agents for Acute Myelogenous Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2000English

P53 in Chronic Myelogenous Leukemia in Acute Phase.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1991English

Differentiation Therapy in Acute Myelogenous Leukemia (Non-Apl)

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2000English

Innovative Approaches in the Treatment and Support of Patients With Acute Myelogenous Leukemia

Oncologist
Cancer ResearchMedicineOncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy